Boothbay Fund Management’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$176K	Buy	+106,459	New	+$176K	﹤0.01%	1072
2020 Q3	–	Sell	-625	Closed	-$78K	–	1125
2020 Q2	$78K	Buy	+625	New	+$78K	0.01%	773
2018 Q4	–	Sell	-444	Closed	-$315K	–	819
2018 Q3	$315K	Buy	+444	New	+$315K	0.03%	379